National Cancer Institute Home at the National Institutes of Health |
Please wait while this form is being loaded....
The Applied Research Program Web site is no longer maintained. ARP's former staff have moved to the new Healthcare Delivery Research Program, the Behavioral Research Program, or the Epidemiology & Genomics Research Program, and the content from this Web site is being moved to one of those sites as appropriate. Please update your links and bookmarks!

Publication Abstract

Authors: Sickles EA

Title: Management of probably benign breast lesions.

Journal: Radiol Clin North Am 33(6):1123-30

Date: 1995 Nov

Abstract: Several large-scale prospective clinical studies establish the validity of managing probably benign breast lesions with periodic mammographic surveillance as a safe and effective alternative to immediate tissue diagnosis. This approach to mammographic interpretation is now very widely accepted; the American College of Radiology indeed includes "probably benign - short interval follow-up suggested" as one of the five final assessment categories in the Breast Imaging Reporting and Data System (BI-RADS), which all American radiologists are encouraged to use. There is also general consensus that probably benign interpretations should involve (1) cases restricted to nonpalpable lesions; (2) use of the specific imaging criteria described in the prospective clinical studies; and (3) pre-interpretation comparison with prior mammograms, if available, to ensure that new or progressing lesions undergo prompt biopsy (it makes no sense to recommend follow-up for a lesion that has already demonstrated interval progression when the very demonstration of progression during surveillance is what prompts biopsy instead of continued follow-up). As yet unresolved issues concerning probably benign lesions include whether initial full problem-solving imaging should be performed in all cases, whether to use patient age and lesion size (for solitary masses) as additional criteria in deciding between the management alternatives of mammographic follow-up and immediate tissue diagnosis, and what should be the specific timing, frequency, and duration of the follow-up examinations that constitute the surveillance protocol.

Last Modified: 03 Sep 2013